RCKTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA
Should you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.
Rocket Pharmaceuticals vs. Its Competitors
180 Life Sciences (NASDAQ:ATNFW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.
In the previous week, Rocket Pharmaceuticals had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for Rocket Pharmaceuticals and 0 mentions for 180 Life Sciences. Rocket Pharmaceuticals' average media sentiment score of 0.37 beat 180 Life Sciences' score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media.
Summary
Rocket Pharmaceuticals beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.
Get Rocket Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RCKTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
RCKTW vs. The Competition
Rocket Pharmaceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:RCKTW) was last updated on 7/9/2025 by MarketBeat.com Staff
Free RCKTW Stock Alerts